iPSC-Derived NK Cells Pipeline The iPSC-derived NK cells therapeutic landscape is entering a transformative phase, driven by cutting-edge advancements in cellular engineering, scalable manufacturing, and next-generation immuno-oncology approaches. iPSC-Derived NK
iPSC-Derived NK Cells Pipeline Set to Transform Cancer Immunotherapy Landscape with 15+ Emerging Therapies and Strong Innovation Momentum from Century Therapeutics, Fate Therapeutics | DelveInsight
Laser Welding Machine Market From battery assembly lines to aerospace fabrication, laser welding technology is becoming an indispensable pillar of modern industrial production — and the growth numbers reflect it.
As personalization becomes the defining theme of modern weddings, laser engraving and cutting technology is rapidly transforming how couples design their big day. From laser cut wedding invitations to personalized
Idiopathic Pulmonary Fibrosis Pipeline Insight There are 80+ key companies, including Bristol-Myers Squibb, Genentech, Tvardi Therapeutics, Melius Pharma, Resproly, and others, developing therapies for Idiopathic Pulmonary Fibrosis, with Bristol-Myers Squibb
B-cell Lymphoma Pipeline Insight There are 295+ key companies, including Bristol Myers Squibb, Roche, Nektar Therapeutics, Miltenyi Biotec, and others,
Liver Cancer Pipeline Insight There are 70+ key companies, including Can-Fite BioPharma, Yiviva, Tvardi Therapeutics, Biosion, Novartis, Roche, and others,
Antisense Oligonucleotide Therapeutics Pipeline Insights The Antisense Oligonucleotide landscape features 70+ key companies, including Novartis, Wave Life Sciences, Bio-Path Holdings,
Ophthalmic Devices Market The global ophthalmic devices market is entering a transformative growth phase, fueled by a surge in eye-related
DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in
DelveInsight’s “Marginal Zone Lymphoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the
